Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine.

Autor: Deliyannis G; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Gherardin NA; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Wong CY; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Grimley SL; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Cooney JP; Walter and Eliza Hall Institute, Infectious Diseases & Immune Defence Division, Parkville, Victoria 3052, Australia., Redmond SJ; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Ellenberg P; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Davidson KC; Walter and Eliza Hall Institute, Infectious Diseases & Immune Defence Division, Parkville, Victoria 3052, Australia., Mordant FL; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Smith T; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Gillard M; Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia., Lopez E; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., McAuley J; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Tan CW; Duke NUS Medical School, Programme for Emerging Infectious Diseases, Singapore., Wang JJ; Department of Immunology, Flinders University and SA Pathology, Flinders Medical Centre, Bedford Park, Adelaide, South Australia 5042, Australia., Zeng W; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Littlejohn M; Doherty Directorate, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Zhou R; Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China., Fuk-Woo Chan J; Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China., Chen ZW; Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China., Hartwig AE; Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Bowen R; Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA., Mackenzie JM; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Vincan E; Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Torresi J; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Kedzierska K; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Pouton CW; Monash Institute of Pharmaceutical Sciences, Parkville, Victoria 3052, Australia., Gordon TP; Department of Immunology, Flinders University and SA Pathology, Flinders Medical Centre, Bedford Park, Adelaide, South Australia 5042, Australia., Wang LF; Duke NUS Medical School, Programme for Emerging Infectious Diseases, Singapore., Kent SJ; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Wheatley AK; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Lewin SR; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, 3010 Australia., Subbarao K; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia; WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Chung AW; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Pellegrini M; Walter and Eliza Hall Institute, Infectious Diseases & Immune Defence Division, Parkville, Victoria 3052, Australia., Munro T; Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia., Nolan T; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia; Vaccine and Immunisation Research Group (VIRGo), Department of Infectious Disease, Peter Doherty Institute for Infection and Immunity, University of Melbourne, and Murdoch Children's Research Institute, Victoria 3010, Australia., Rockman S; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia; Seqirus, Vaccine Innovation Unit, Parkville, Victoria, 3052, Australia., Jackson DC; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Purcell DFJ; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia., Godfrey DI; Department of Microbiology & Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria 3000, Australia. Electronic address: godfrey@unimelb.edu.au.

Publikováno v: EBioMedicine [EBioMedicine] 2023 Jun; Vol. 92, pp. 104574. Date of Electronic Publication: 2023 May 04.

American alligators are capable of West Nile virus amplification, mosquito infection and transmission.

Autor: Byas AD; Colorado State University, Microbiology, Immunology & Pathology Department, Fort Collins, CO, USA., Gallichotte EN; Colorado State University, Microbiology, Immunology & Pathology Department, Fort Collins, CO, USA., Hartwig AE; Colorado State University, Biomedical Sciences Department, Fort Collins, CO, USA., Porter SM; Colorado State University, Microbiology, Immunology & Pathology Department, Fort Collins, CO, USA., Gordy PW; Colorado State University, Biomedical Sciences Department, Fort Collins, CO, USA., Felix TA; United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, Lakewood, CO, USA., Bowen RA; Colorado State University, Biomedical Sciences Department, Fort Collins, CO, USA., Ebel GD; Colorado State University, Microbiology, Immunology & Pathology Department, Fort Collins, CO, USA., Bosco-Lauth AM; Colorado State University, Biomedical Sciences Department, Fort Collins, CO, USA. Electronic address: angela.bosco-lauth@colostate.edu.

Publikováno v: Virology [Virology] 2022 Mar; Vol. 568, pp. 49-55. Date of Electronic Publication: 2022 Jan 24.

Peridomestic Mammal Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Autor: Bosco-Lauth AM, Root JJ, Porter SM, Walker AE, Guilbert L, Hawvermale D, Pepper A, Maison RM, Hartwig AE, Gordy P, Bielefeldt-Ohmann H, Bowen RA

Publikováno v: Emerging infectious diseases [Emerg Infect Dis] 2021 Aug; Vol. 27 (8), pp. 2073-2080.

Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats.

Autor: Bosco-Lauth AM; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523 angela.bosco-lauth@colostate.edu., Hartwig AE; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523., Porter SM; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523., Gordy PW; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523., Nehring M; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523., Byas AD; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523., VandeWoude S; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523., Ragan IK; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523., Maison RM; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523., Bowen RA; College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Oct 20; Vol. 117 (42), pp. 26382-26388. Date of Electronic Publication: 2020 Sep 29.

Shedding of clade 2.3.4.4 H5N8 and H5N2 highly pathogenic avian influenza viruses in peridomestic wild birds in the U.S.

Autor: Bosco-Lauth AM; Colorado State University, Fort Collins, Colorado., Marlenee NL; Colorado State University, Fort Collins, Colorado., Hartwig AE; Colorado State University, Fort Collins, Colorado., Bowen RA; Colorado State University, Fort Collins, Colorado., Root JJ; United States Department of Agriculture, National Wildlife Research Center, Fort Collins, Colorado.

Publikováno v: Transboundary and emerging diseases [Transbound Emerg Dis] 2019 May; Vol. 66 (3), pp. 1301-1305. Date of Electronic Publication: 2019 Mar 05.